miDiagnostics
miDiagnostics
miDiagnostics is a Belgium based medical devices company with the mission to provide a comprehensive range of health screening tools that will eventually grant diagnostic access for everyone, everywhere, and at any time.
Website
www.midiagnostics.com
Entry
2015
What do we do?
This is achieved by miniaturizing and simplifying the diagnostics process using silicon chips. The company is developing a molecular diagnostics pipeline, using its ultra-fast PCR technology for the diagnosis of SARS-CoV-2, with menu expansion possibilities towards any other molecular test that could merit the benefits of decentralization, diagnostic accuracy, and ease of use.
"Innovation needs to deliver functionality that addresses real market needs, which is exactly what we’re working on at miDiagnostics. I believe our technology will be truly disruptive in the diagnostics field."
Katleen Verleysen, CEO – miDiagnostics
miDiagnostics’ dream
miDiagnostics’ mission is to take accurate diagnostics out of the centralized setting, much closer to the point of need, enabling doctors to provide a precise diagnosis and treatment during the consultation with their patients.
MORE INVESTMENTS
Alychlo invests directly in companies, makes select fund investments and manages a long-term small- and mid-cap equities portfolio.
